Sign Up

About ARALAST NP Therapy

ARALAST NP ARALAST NP

Help for Your Patients

The resources in this section are designed to help your Alpha-1 patients effectively manage their condition.

Of particular interest is the ARALAST NP AATmosphere Program, which offers a comprehensive support program for Alphas and their families.

Insurance coverage is often a concern for Alphas and their families. Visit the Insurance Assistance page for a listing of helpful services.

Your patients can learn more about AAT Deficiency with the Patient Education Kits and Brochures.

We encourage you to refer your patients to the Patients and Families side of Alpha1Health.com for a wealth of useful information and helpful resources.

ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]

ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Please review the Important Risk Information and the Full Prescribing Information

Please review the Important Risk Information and the Full Prescribing Information